Submitted by Anonymous (not verified) on 17 April 2026 - 8:54
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised